186 related articles for article (PubMed ID: 34089583)
1. Axillary evaluation in ductal cancer in situ of the breast: challenging the diagnostic accuracy of clinical practice guidelines.
Karakatsanis A; Charalampoudis P; Pistioli L; Di Micco R; Foukakis T; Valachis A;
Br J Surg; 2021 Sep; 108(9):1120-1125. PubMed ID: 34089583
[TBL] [Abstract][Full Text] [Related]
2. Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study.
Karakatsanis A; Eriksson S; Pistiolis L; Olofsson Bagge R; Nagy G; Man V; Kwong A; Wärnberg F;
Ann Surg Oncol; 2023 Jul; 30(7):4064-4072. PubMed ID: 36719570
[TBL] [Abstract][Full Text] [Related]
3. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
[TBL] [Abstract][Full Text] [Related]
4. DCIS and axillary nodal evaluation: compliance with national guidelines.
Mitchell KB; Lin H; Shen Y; Colfry A; Kuerer H; Shaitelman SF; Babiera GV; Bedrosian I
BMC Surg; 2017 Feb; 17(1):12. PubMed ID: 28173790
[TBL] [Abstract][Full Text] [Related]
5. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
6. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
[TBL] [Abstract][Full Text] [Related]
7. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ
Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis.
Davey MG; O'Flaherty C; Cleere EF; Nohilly A; Phelan J; Ronane E; Lowery AJ; Kerin MJ
BJS Open; 2022 Mar; 6(2):. PubMed ID: 35380620
[TBL] [Abstract][Full Text] [Related]
9. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
[TBL] [Abstract][Full Text] [Related]
10. The role of sentinel lymph node biopsy in ductal carcinoma in situ.
Moran CJ; Kell MR; Kerin MJ
Eur J Surg Oncol; 2005 Dec; 31(10):1105-11. PubMed ID: 16084681
[TBL] [Abstract][Full Text] [Related]
11. Is Axillary Assessment of Ductal Carcinoma In Situ of the Breast Necessary in All Cases?
Bellver G; Buch E; Ripoll F; Adrianzen M; Bermejo B; Burgues O; Julve A; Ortega J
J Surg Res; 2022 Mar; 271():145-153. PubMed ID: 34902737
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
13. Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study).
Karakatsanis A; Hersi AF; Pistiolis L; Olofsson Bagge R; Lykoudis PM; Eriksson S; Wärnberg F;
Br J Surg; 2019 May; 106(6):720-728. PubMed ID: 30839104
[TBL] [Abstract][Full Text] [Related]
14. Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast.
Usmani S; Khan HA; Al Saleh N; abu Huda F; Marafi F; Amanguno HG; Al Nafisi N; Al Kandari F
Nucl Med Commun; 2011 Nov; 32(11):1084-7. PubMed ID: 21862942
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy in ductal carcinoma in situ patients.
Pendas S; Dauway E; Giuliano R; Ku N; Cox CE; Reintgen DS
Ann Surg Oncol; 2000; 7(1):15-20. PubMed ID: 10674443
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
Klauber-DeMore N; Tan LK; Liberman L; Kaptain S; Fey J; Borgen P; Heerdt A; Montgomery L; Paglia M; Petrek JA; Cody HS; Van Zee KJ
Ann Surg Oncol; 2000 Oct; 7(9):636-42. PubMed ID: 11034239
[TBL] [Abstract][Full Text] [Related]
17. The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.
Tunon-de-Lara C; Chauvet MP; Baranzelli MC; Baron M; Piquenot J; Le-Bouédec G; Penault-Llorca F; Garbay JR; Blanchot J; Mollard J; Maisongrosse V; Mathoulin-Pélissier S; MacGrogan G
Ann Surg Oncol; 2015 Nov; 22(12):3853-60. PubMed ID: 25777085
[TBL] [Abstract][Full Text] [Related]
18. Utility of intraoperative frozen section examination of sentinel lymph nodes in ductal carcinoma in situ of the breast.
Ballehaninna UK; Chamberlain RS
Clin Breast Cancer; 2013 Oct; 13(5):350-8. PubMed ID: 23791128
[TBL] [Abstract][Full Text] [Related]
19. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
Shin YD; Lee HM; Choi YJ
BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy for localised ductal carcinoma in situ?
Veronesi P; Intra M; Vento AR; Naninato P; Caldarella P; Paganelli G; Viale G
Breast; 2005 Dec; 14(6):520-2. PubMed ID: 16185871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
